Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Free Subscription

Articles published in Gut

Retrieve available abstracts of 107 articles:
HTML format

Single Articles

    June 2020

  1. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas screening (CAPS) Consortium.
    Gut. 2020;69:e3.

    May 2020
  2. KNUDSEN ES, Kumarasamy V, Chung S, Ruiz A, et al
    Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer.
    Gut. 2020 May 18. pii: gutjnl-2020-321000. doi: 10.1136/gutjnl-2020-321000.
    PubMed     Abstract available

  3. MOLINA-MONTES E, Coscia C, Gomez-Rubio P, Fernandez A, et al
    Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Gut. 2020 May 14. pii: gutjnl-2019-319990. doi: 10.1136/gutjnl-2019-319990.
    PubMed     Abstract available

  4. TAKAHASHI R, Macchini M, Sunagawa M, Jiang Z, et al
    Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Gut. 2020 May 10. pii: gutjnl-2019-319912. doi: 10.1136/gutjnl-2019-319912.
    PubMed     Abstract available

    April 2020
  5. LUCHINI C, Brosens LAA, Wood LD, Chatterjee D, et al
    Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
    Gut. 2020 Apr 29. pii: gutjnl-2020-320726. doi: 10.1136/gutjnl-2020-320726.
    PubMed     Abstract available

  6. TIAN J, Zhu Y, Rao M, Cai Y, et al
    N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
    Gut. 2020 Apr 20. pii: gutjnl-2019-320179. doi: 10.1136/gutjnl-2019-320179.
    PubMed     Abstract available

  7. DE-MADARIA E, Sanchez-Marin C, Carrillo I, Vege SS, et al
    Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study.
    Gut. 2020 Apr 3. pii: gutjnl-2020-320729. doi: 10.1136/gutjnl-2020-320729.
    PubMed     Abstract available

    February 2020
  8. BANG JY, Hawes RH, Varadarajulu S
    Lumen-apposing metal stent placement for drainage of pancreatic fluid collections: predictors of adverse events.
    Gut. 2020 Feb 17. pii: gutjnl-2019-320539. doi: 10.1136/gutjnl-2019-320539.

  9. STOLZENBERG-SOLOMON R, Derkach A, Moore S, Weinstein SJ, et al
    Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319811. doi: 10.1136/gutjnl-2019-319811.
    PubMed     Abstract available

    January 2020
  10. BIEDERSTADT A, Hassan Z, Schneeweis C, Schick M, et al
    SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856.
    PubMed     Abstract available

  11. WAN J, Haddock A, Edenfield B, Ji B, et al
    Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.
    Gut. 2020 Jan 23. pii: gutjnl-2019-320399. doi: 10.1136/gutjnl-2019-320399.

    December 2019
  12. FRAMPTON AE, Giovannetti E
    Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles.
    Gut. 2019 Dec 4. pii: gutjnl-2019-319896. doi: 10.1136/gutjnl-2019-319896.

    October 2019
  13. GOGGINS M, Overbeek KA, Brand R, Syngal S, et al
    Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352.
    PubMed     Abstract available

  14. LIANG C, Shi S, Qin Y, Meng Q, et al
    Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2019 Oct 14. pii: gutjnl-2018-317163. doi: 10.1136/gutjnl-2018-317163.
    PubMed     Abstract available

  15. TOLOSA EJ, Fernandez-Zapico ME
    Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer.
    Gut. 2019 Oct 3. pii: gutjnl-2019-318962. doi: 10.1136/gutjnl-2019-318962.

    September 2019
  16. YU S, Li Y, Liao Z, Wang Z, et al
    Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318860. doi: 10.1136/gutjnl-2019-318860.
    PubMed     Abstract available

  17. HEGYI E, Toth AZ, Vincze A, Szentesi A, et al
    Alcohol-dependent effect of PRSS1-PRSS2 haplotype in chronic pancreatitis.
    Gut. 2019 Sep 10. pii: gutjnl-2019-319729. doi: 10.1136/gutjnl-2019-319729.

    August 2019
  18. HONG X, Qiao S, Li F, Wang W, et al
    Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system.
    Gut. 2019 Aug 28. pii: gutjnl-2018-317233. doi: 10.1136/gutjnl-2018-317233.
    PubMed     Abstract available

    July 2019
  19. NIU N, Lu P, Yang Y, He R, et al
    Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2019 Jul 11. pii: gutjnl-2019-318362. doi: 10.1136/gutjnl-2019-318362.
    PubMed     Abstract available

  20. BANG JY, Navaneethan U, Hasan MK, Sutton B, et al
    Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial.
    Gut. 2019;68:1200-1209.
    PubMed     Abstract available

    June 2019
  21. N KALIMUTHU S, Wilson GW, Grant RC, Seto M, et al
    Morphological classification of pancreatic ductal adenocarcinoma that predicts molecular subtypes and correlates with clinical outcome.
    Gut. 2019 Jun 14. pii: gutjnl-2019-318217. doi: 10.1136/gutjnl-2019-318217.
    PubMed     Abstract available

  22. COLLET L, Ghurburrun E, Meyers N, Assi M, et al
    Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells.
    Gut. 2019 Jun 1. pii: gutjnl-2018-318059. doi: 10.1136/gutjnl-2018-318059.
    PubMed     Abstract available

    May 2019
  23. SUN C, Liu M, An W, Mao X, et al
    Heterozygous Spink1 c.194+2T>C mutant mice spontaneously develop chronic pancreatitis.
    Gut. 2019 May 29. pii: gutjnl-2019-318790. doi: 10.1136/gutjnl-2019-318790.

  24. DREWES AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, et al
    Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!
    Gut. 2019 May 25. pii: gutjnl-2019-318742. doi: 10.1136/gutjnl-2019-318742.

  25. JIANG H, Liu X, Knolhoff BL, Hegde S, et al
    Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.
    Gut. 2019 May 10. pii: gutjnl-2018-317424. doi: 10.1136/gutjnl-2018-317424.
    PubMed     Abstract available

    April 2019
  26. NEMETH BC, Orekhova A, Zhang W, Nortman SA, et al
    Novel p.K374E variant of CPA1 causes misfolding-induced hereditary pancreatitis with autosomal dominant inheritance.
    Gut. 2019 Apr 20. pii: gutjnl-2019-318751. doi: 10.1136/gutjnl-2019-318751.

  27. BENITZ S, Straub T, Mahajan UM, Mutter J, et al
    Ring1b-dependent epigenetic remodelling is an essential prerequisite for pancreatic carcinogenesis.
    Gut. 2019 Apr 6. pii: gutjnl-2018-317208. doi: 10.1136/gutjnl-2018-317208.
    PubMed     Abstract available

  28. Correction: Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP.
    Gut. 2019 Apr 3. pii: gutjnl-2014-308553.

    March 2019
  29. HESSMANN E, Ellenrieder V
    Chromatin remodelling controls pancreatic tissue fate.
    Gut. 2019 Mar 19. pii: gutjnl-2018-317486. doi: 10.1136/gutjnl-2018-317486.

  30. GAISER RA, Halimi A, Alkharaan H, Lu L, et al
    Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer.
    Gut. 2019 Mar 14. pii: gutjnl-2018-317458. doi: 10.1136/gutjnl-2018-317458.
    PubMed     Abstract available

  31. LIN JH, Boulling A, Masson E, Cooper DN, et al
    Most unambiguous loss-of-function CPA1 mutations are unlikely to predispose to chronic pancreatitis.
    Gut. 2019 Mar 12. pii: gutjnl-2019-318564. doi: 10.1136/gutjnl-2019-318564.

  32. JIANG SH, Zhu LL, Zhang M, Li RK, et al
    GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner.
    Gut. 2019 Mar 2. pii: gutjnl-2018-317479. doi: 10.1136/gutjnl-2018-317479.
    PubMed     Abstract available

  33. Correction: Comprehensive characterisation ofcompartment-specific long non-coding RNAs associated with pancreatic ductaladenocarcinoma.
    Gut. 2019 Mar 2. pii: gutjnl-2017-314353.

    February 2019
  34. SINGH S, Hasselluhn MC, Neesse A
    A tangled tale of molecular subtypes in pancreatic cancer.
    Gut. 2019 Feb 27. pii: gutjnl-2018-318086. doi: 10.1136/gutjnl-2018-318086.

  35. KATO Y, Azuma K, Someda H, Shiokawa M, et al
    Case of IgG4-associated sclerosing cholangitis with normal serum IgG4 concentration, diagnosed by anti-laminin 511-E8 antibody: a novel autoantibody in patients with autoimmune pancreatitis.
    Gut. 2019 Feb 13. pii: gutjnl-2018-317934. doi: 10.1136/gutjnl-2018-317934.

  36. SHI N, Liu T, de la Iglesia-Garcia D, Deng L, et al
    Duration of organ failure impacts mortality in acute pancreatitis.
    Gut. 2019 Feb 11. pii: gutjnl-2019-318241. doi: 10.1136/gutjnl-2019-318241.

    January 2019
  37. ZHAO Q, Manohar M, Wei Y, Pandol SJ, et al
    STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2019 Jan 31. pii: gutjnl-2018-317098. doi: 10.1136/gutjnl-2018-317098.
    PubMed     Abstract available

  38. MAURER HC, Holmstrom SR, He J, Laise P, et al
    Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
    Gut. 2019 Jan 18. pii: gutjnl-2018-317706. doi: 10.1136/gutjnl-2018-317706.
    PubMed     Abstract available

    December 2018
  39. BAUER CA
    Immunosuppressive betaig-h3 links tumour stroma and dysfunctional T cells in pancreatic cancer.
    Gut. 2018 Dec 7. pii: gutjnl-2018-317735. doi: 10.1136/gutjnl-2018-317735.

    November 2018
  40. BANG JY, Varadarajulu S
    Authors reply: treatment strategy for necrotising pancreatitis.
    Gut. 2018 Nov 17. pii: gutjnl-2018-317848. doi: 10.1136/gutjnl-2018-317848.

  41. GOEHRIG D, Nigri J, Samain R, Wu Z, et al
    Stromal protein betaig-h3 reprogrammes tumour microenvironment in pancreatic cancer.
    Gut. 2018 Nov 10. pii: gutjnl-2018-317570. doi: 10.1136/gutjnl-2018-317570.
    PubMed     Abstract available

  42. CONWAY JR, Herrmann D, Evans TJ, Morton JP, et al
    Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine.
    Gut. 2018 Nov 5. pii: gutjnl-2018-316822. doi: 10.1136/gutjnl-2018-316822.
    PubMed     Abstract available

    October 2018
  43. LUNA J, Boni J, Cuatrecasas M, Bofill-De Ros X, et al
    DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
    Gut. 2018 Oct 20. pii: gutjnl-2018-316128. doi: 10.1136/gutjnl-2018-316128.
    PubMed     Abstract available

  44. KOUTSIOUMPA M, Hatziapostolou M, Polytarchou C, Tolosa EJ, et al
    Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.
    Gut. 2018 Oct 18. pii: gutjnl-2017-315690. doi: 10.1136/gutjnl-2017-315690.
    PubMed     Abstract available

  45. WANG SC, Nassour I, Xiao S, Zhang S, et al
    SWI/SNF component ARID1A restrains pancreatic neoplasia formation.
    Gut. 2018 Oct 12. pii: gutjnl-2017-315490. doi: 10.1136/gutjnl-2017-315490.
    PubMed     Abstract available

  46. PUPPA G, Christinat Y, McKee TA
    Towards optimal pancreatic cyst fluid management: the need for standardisation.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317156. doi: 10.1136/gutjnl-2018-317156.

    September 2018
  47. NEESSE A, Bauer CA, Ohlund D, Lauth M, et al
    Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
    Gut. 2018 Sep 3. pii: gutjnl-2018-316451. doi: 10.1136/gutjnl-2018-316451.
    PubMed     Abstract available

    August 2018
  48. RAJ D, Yang MH, Rodgers D, Hampton EN, et al
    Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
    Gut. 2018 Aug 18. pii: gutjnl-2018-316595. doi: 10.1136/gutjnl-2018-316595.
    PubMed     Abstract available

    Unfolding the mystery of digestive enzyme misfolding in chronic pancreatitis.
    Gut. 2018 Aug 3. pii: gutjnl-2018-316985. doi: 10.1136/gutjnl-2018-316985.

    July 2018
  50. HEGYI E, Sahin-Toth M
    Human CPA1 mutation causes digestive enzyme misfolding and chronic pancreatitis in mice.
    Gut. 2018 Jul 25. pii: gutjnl-2018-315994. doi: 10.1136/gutjnl-2018-315994.
    PubMed     Abstract available

    June 2018
  51. SCHEPERS NJ, Bakker OJ, Besselink MG, Ahmed Ali U, et al
    Impact of characteristics of organ failure and infected necrosis on mortality in necrotising pancreatitis.
    Gut. 2018 Jun 27. pii: gutjnl-2017-314657. doi: 10.1136/gutjnl-2017-314657.
    PubMed     Abstract available

    May 2018
  52. IKUTA K, Fukuda A, Ogawa S, Masuo K, et al
    Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice.
    Gut. 2018 May 24. pii: gutjnl-2017-315425. doi: 10.1136/gutjnl-2017-315425.
    PubMed     Abstract available

  53. Correction: Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2018;67:994.

    April 2018
  54. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.

  55. ZEISSIG S, Sulk S, Brueckner S, Matthes K, et al
    Severe bleeding is a rare event in patients receiving lumen-apposing metal stents for the drainage of pancreatic fluid collections.
    Gut. 2018 Apr 20. pii: gutjnl-2018-316581. doi: 10.1136/gutjnl-2018-316581.

  56. ENEA A, Pizzol A, Pinon M, Cisaro F, et al
    Hereditary pancreatitis in Paediatrics: the causative role of p.Leu104Pro mutation of cationic trypsinogen gene also in young subjects.
    Gut. 2018 Apr 17. pii: gutjnl-2018-316443. doi: 10.1136/gutjnl-2018-316443.

  57. SCARPA A, Real FX, Luchini C
    Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management.
    Gut. 2018 Apr 16. pii: gutjnl-2018-316151. doi: 10.1136/gutjnl-2018-316151.

  58. HUBERS LM, Vos H, Schuurman AR, Erken R, et al
    Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease.
    Gut. 2018;67:728-735.
    PubMed     Abstract available

    March 2018

  59. European evidence-based guidelines on pancreatic cystic neoplasms.
    Gut. 2018 Mar 24. pii: gutjnl-2018-316027. doi: 10.1136/gutjnl-2018-316027.
    PubMed     Abstract available

  60. YANG N, Li B, Pan Y, Tu J, et al
    Hypertriglyceridaemia delays pancreatic regeneration after acute pancreatitis in mice and patients.
    Gut. 2018 Mar 16. pii: gutjnl-2017-315560. doi: 10.1136/gutjnl-2017-315560.

    February 2018
  61. ARNES L, Liu Z, Wang J, Maurer HC, et al
    Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma.
    Gut. 2018 Feb 10. pii: gutjnl-2017-314353. doi: 10.1136/gutjnl-2017-314353.
    PubMed     Abstract available

    January 2018
  62. LEE AYL, Dubois CL, Sarai K, Zarei S, et al
    Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Gut. 2018 Jan 23. pii: gutjnl-2017-314426. doi: 10.1136/gutjnl-2017-314426.
    PubMed     Abstract available

    December 2017
  63. MICHL P, Krug S
    Overcoming immune evasion in pancreatic cancer: the combination matters.
    Gut. 2017 Dec 7. pii: gutjnl-2017-315443. doi: 10.1136/gutjnl-2017-315443.

  64. NYWENING TM, Belt BA, Cullinan DR, Panni RZ, et al
    Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.
    Gut. 2017 Dec 1. pii: gutjnl-2017-313738. doi: 10.1136/gutjnl-2017-313738.
    PubMed     Abstract available

  65. WU H, Boulling A, Cooper DN, Li ZS, et al
    In vitro and in silico evidence against a significant effect of the SPINK1 c.194G>A variant on pre-mRNA splicing.
    Gut. 2017;66:2195-2196.

    November 2017
  66. HUANG L, Jansen L, Balavarca Y, Molina-Montes E, et al
    Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations.
    Gut. 2017 Nov 20. pii: gutjnl-2017-314828. doi: 10.1136/gutjnl-2017-314828.
    PubMed     Abstract available

    October 2017
  67. CHOU A, Froio D, Nagrial AM, Parkin A, et al
    Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315144. doi: 10.1136/gutjnl-2017-315144.
    PubMed     Abstract available

  68. NOTTA F, Hahn SA, Real FX
    A genetic roadmap of pancreatic cancer: still evolving.
    Gut. 2017 Oct 9. pii: gutjnl-2016-313317. doi: 10.1136/gutjnl-2016-313317.
    PubMed     Abstract available

  69. BANG JY, Hebert-Magee S, Navaneethan U, Hasan MK, et al
    EUS-guided fine needle biopsy of pancreatic masses can yield true histology: results of a randomised trial.
    Gut. 2017 Oct 7. pii: gutjnl-2017-315154. doi: 10.1136/gutjnl-2017-315154.

    September 2017
  70. SINGHI AD, McGrath K, Brand RE, Khalid A, et al
    Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Gut. 2017 Sep 28. pii: gutjnl-2016-313586. doi: 10.1136/gutjnl-2016-313586.
    PubMed     Abstract available

  71. TANG XY, Zou WB, Masson E, Hu LH, et al
    The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.
    Gut. 2017 Sep 26. pii: gutjnl-2017-315180. doi: 10.1136/gutjnl-2017-315180.

  72. HOPPER AD, Campbell JA
    Improving future studies in chronic pancreatitis: a paradigm shift in our understanding?
    Gut. 2017 Sep 22. pii: gutjnl-2017-315067. doi: 10.1136/gutjnl-2017-315067.

  73. KROMREY ML, Bulow R, Hubner J, Paperlein C, et al
    Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study.
    Gut. 2017 Sep 6. pii: gutjnl-2016-313127. doi: 10.1136/gutjnl-2016-313127.
    PubMed     Abstract available

    August 2017
  74. VAN DIJK SM, Hallensleben NDL, van Santvoort HC, Fockens P, et al
    Acute pancreatitis: recent advances through randomised trials.
    Gut. 2017 Aug 24. pii: gutjnl-2016-313595. doi: 10.1136/gutjnl-2016-313595.
    PubMed     Abstract available

  75. IORIO V, Rosati A, D'Auria R, De Marco M, et al
    Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8+ T cell number and tumour growth in pancreatic cancer.
    Gut. 2017 Aug 11. pii: gutjnl-2017-314225. doi: 10.1136/gutjnl-2017-314225.

  76. SARR MG
    Minimal access necrosectomy: the newest advance of many in the treatment of necrotising pancreatitis.
    Gut. 2017 Aug 10. pii: gutjnl-2017-314660. doi: 10.1136/gutjnl-2017-314660.

  77. SELEZNIK GM, Reding T, Peter L, Gupta A, et al
    Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313458. doi: 10.1136/gutjnl-2016-313458.
    PubMed     Abstract available

  78. VAN BRUNSCHOT S, Hollemans RA, Bakker OJ, Besselink MG, et al
    Minimally invasive and endoscopic versus open necrosectomy for necrotising pancreatitis: a pooled analysis of individual data for 1980 patients.
    Gut. 2017 Aug 3. pii: gutjnl-2016-313341. doi: 10.1136/gutjnl-2016-313341.
    PubMed     Abstract available

  79. SINGH VP
    High on drugs: lessons from opiates in pancreatitis.
    Gut. 2017 Aug 1. pii: gutjnl-2017-314506. doi: 10.1136/gutjnl-2017-314506.

    July 2017
  80. ROSENDAHL J, Kirsten H, Hegyi E, Kovacs P, et al
    Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.
    Gut. 2017 Jul 28. pii: gutjnl-2017-314454. doi: 10.1136/gutjnl-2017-314454.
    PubMed     Abstract available

    June 2017
  81. SCARPA A, Mafficini A
    Non-coding regulatory variations: the dark matter of pancreatic cancer genomics.
    Gut. 2017 Jun 28. pii: gutjnl-2017-314310. doi: 10.1136/gutjnl-2017-314310.

  82. BARLASS U, Dutta R, Cheema H, George J, et al
    Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis.
    Gut. 2017 Jun 22. pii: gutjnl-2017-313717. doi: 10.1136/gutjnl-2017-313717.
    PubMed     Abstract available

  83. ZHANG M, Lykke-Andersen S, Zhu B, Xiao W, et al
    Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
    Gut. 2017 Jun 20. pii: gutjnl-2016-313146. doi: 10.1136/gutjnl-2016-313146.
    PubMed     Abstract available

  84. GOYAL J, Barkin JA, Barkin JS
    Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314460. doi: 10.1136/gutjnl-2017-314460.

  85. MASSON E, Chen JM, Cooper DN, Ferec C, et al
    PRSS1 copy number variants and promoter polymorphisms in pancreatitis: common pathogenetic mechanism, different genetic effects.
    Gut. 2017 Jun 10. pii: gutjnl-2017-314443. doi: 10.1136/gutjnl-2017-314443.

    May 2017
    A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis.
    Gut. 2017 May 24. pii: gutjnl-2016-313665. doi: 10.1136/gutjnl-2016-313665.

    March 2017
  87. ZHU H, Lin H, Jin Z, Du Y, et al
    Re-evaluation of the role of lumen-apposing metal stents (LAMS) for pancreatic fl uid collection drainage.
    Gut. 2017 Mar 17. pii: gutjnl-2017-313949. doi: 10.1136/gutjnl-2017-313949.

  88. KUJKO AA, Berki DM, Oracz G, Wejnarska K, et al
    A novel p.Ser282Pro CPA1 variant is associated with autosomal dominant hereditary pancreatitis.
    Gut. 2017 Mar 3. pii: gutjnl-2017-313816. doi: 10.1136/gutjnl-2017-313816.

    February 2017
  89. SANCHEZ-AREVALO LOBO VJ, Fernandez LC, Carrillo-de-Santa-Pau E, Richart L, et al
    c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis.
    Gut. 2017 Feb 3. pii: gutjnl-2016-312306. doi: 10.1136/gutjnl-2016-312306.
    PubMed     Abstract available

    January 2017
    Pancreatic enzyme replacement therapy in chronic pancreatitis: a long way to go.
    Gut. 2017 Jan 27. pii: gutjnl-2016-313455. doi: 10.1136/gutjnl-2016-313455.

  91. WILLIAMS E, Beckingham I, El Sayed G, Gurusamy K, et al
    Updated guideline on the management of common bile duct stones (CBDS).
    Gut. 2017 Jan 25. pii: gutjnl-2016-312317. doi: 10.1136/gutjnl-2016-312317.
    PubMed     Abstract available

  92. MAYERLE J, Kalthoff H, Reszka R, Kamlage B, et al
    Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Gut. 2017 Jan 20. pii: gutjnl-2016-312432. doi: 10.1136/gutjnl-2016-312432.
    PubMed     Abstract available

  93. STECHER SS, Simon P, Friesecke S, Glitsch A, et al
    Delayed severe bleeding complications after treatment of pancreatic fluid collections with lumen-apposing metal stents.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313562. doi: 10.1136/gutjnl-2016-313562.

  94. KNUDSEN ES, Balaji U, Mannakee B, Vail P, et al
    Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313133. doi: 10.1136/gutjnl-2016-313133.
    PubMed     Abstract available

    December 2016
  95. NEMETH BC, Patai AV, Sahin-Toth M, Hegyi P, et al
    Misfolding cationic trypsinogen variant p.L104P causes hereditary pancreatitis.
    Gut. 2016 Dec 23. pii: gutjnl-2016-313451. doi: 10.1136/gutjnl-2016-313451.

  96. RYAN BM, Venkatachalapathy SV, Huggett MT
    Safety of lumen-apposing metal stents (LAMS) for pancreatic fluid collection drainage.
    Gut. 2016 Dec 16. pii: gutjnl-2016-313388. doi: 10.1136/gutjnl-2016-313388.

  97. DE LA IGLESIA-GARCIA D, Huang W, Szatmary P, Baston-Rey I, et al
    Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    Gut. 2016 Dec 9. pii: gutjnl-2016-312529. doi: 10.1136/gutjnl-2016-312529.
    PubMed     Abstract available

  98. DUELL EJ
    Telomere length and pancreatic cancer risk: breaking down the evidence.
    Gut. 2016 Dec 5. pii: gutjnl-2016-313156. doi: 10.1136/gutjnl-2016-313156.

    November 2016
  99. TEICH N, Bokemeyer B, Mohl W, Walldorf J, et al
    Blood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD.
    Gut. 2016 Nov 14. pii: gutjnl-2016-313138. doi: 10.1136/gutjnl-2016-313138.

  100. LEEDS JS, Nayar MK, Charnley RM, Oppong KW, et al
    Lumen-apposing metal stents for pancreatic fluid collection drainage: may not be business as usual?
    Gut. 2016 Nov 4. pii: gutjnl-2016-313187. doi: 10.1136/gutjnl-2016-313187.

  101. HESSMANN E, Johnsen SA, Siveke JT, Ellenrieder V, et al
    Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
    Gut. 2016 Nov 3. pii: gutjnl-2016-312539. doi: 10.1136/gutjnl-2016-312539.
    PubMed     Abstract available

    October 2016
  102. BAO Y, Prescott J, Yuan C, Zhang M, et al
    Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-312510. doi: 10.1136/gutjnl-2016-312510.
    PubMed     Abstract available

  103. MACE TA, Shakya R, Pitarresi JR, Swanson B, et al
    IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Gut. 2016 Oct 21. pii: gutjnl-2016-311585. doi: 10.1136/gutjnl-2016-311585.
    PubMed     Abstract available

  104. FAN X, Alekseyenko AV, Wu J, Peters BA, et al
    Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.
    Gut. 2016 Oct 14. pii: gutjnl-2016-312580. doi: 10.1136/gutjnl-2016-312580.
    PubMed     Abstract available

  105. HART PA, Chari ST
    Preventing disease relapses in autoimmune pancreatitis with maintenance steroids: are we there yet?
    Gut. 2016 Oct 5. pii: gutjnl-2016-312738. doi: 10.1136/gutjnl-2016-312738.

    September 2016
  106. WILLS ES, Drenth JP
    Building pancreatic organoids to aid drug development.
    Gut. 2016 Sep 21. pii: gutjnl-2016-312865. doi: 10.1136/gutjnl-2016-312865.

  107. KONG B, Bruns P, Behler NA, Chang L, et al
    Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy.
    Gut. 2016 Sep 19. pii: gutjnl-2015-310913. doi: 10.1136/gutjnl-2015-310913.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.